A constructive plan was made public by the national government of South Korea, as it declared on Tuesday, during the writing of this article, that it plans to spend $146 million, for the procurement of coronavirus vaccines, which is an initial aim for securing a supply that will be enough primarily for 30 million people which is equivalent to 60% of its total population, as it combats insistent outbreaks of new cases recorded on a daily basis.
The targeted population of the national government is higher, in comparison to the goal set by the WHO or World Health Organization, regarding the early purchase of supplies, for 20% of the world’s most vulnerable population, and at least 40% in fulfillment of the agreement set on the population percentage agreed jointly by the European Union Nations, British and EU partners.
On the other hand, South Korean authorities would like to come up with the initiative, which is to vaccinate the entirety of the population which is a total of 52 million to be exact, despite the uncertainty that circulates around any vaccine’s efficacy, development and safety in a limited investment. This initiative was placed on the limelight of concern by Prime Minister Chung Sye-kyun, during their respective cabinet meetings.
In relevance to this initiative, global vaccine makers are highly involved in a race that is of time and urgency, with regards to the successful development of an effective vaccine that will hopefully abolish, eradicate and combat the coronavirus, which has dreadfully and horrendously killed 925,000 people and more, worldwide, as its emergence took place in China on the end part of the past year, that brought the globe into a state of pandemic.
Accordingly, Chung explained with utmost emphasis that the national government would continuously promote efforts and initiatives of negotiation, with highly relevant international organizations and vaccine makers, which will directly lead to the relative procurement of supply and secure the surety of buying more as developments continue to unfold and arise as continuous research for an effective vaccine is still in the limelight of study and trial testing.
Last August, the national government of South Korea, expressed in emphasis its intent in joining the COVAX facility, which is renowned as a global novel coronavirus vaccine allocation plan and strategy co-led by the WHO, which directly aims to aid in the purchase and equal distribution of the vaccine shots.
In addition, South Korea’s health authorities explained in an interview with the press that they will purchase 20 million doses of vaccine from the scheme of COVAX, which is enough relatively for 10 million people, and also, 40 million doses from the private drug-makers.
On the financial aspect of the national government’s thrust in South Korea, a total of 172 billion won which is equivalent to $146 million is prepared by the officials concerned in order to purchase and procure the vaccines, which includes the 70$ million intended for the 20 million doses that will come from the COVAX facility.
In the global scheme, South Korea has been one of the world’s greatly renowned coronavirus mitigation success stories, which features its joint and united efforts of effective tracing strategy and aggressive testing facility, but these have nevertheless been combating insistent spikes of infections and transmissions on a daily basis.
Alongside with these developments and in the duration of writing this article, 106 fresh coronavirus cases were tallied in accumulation last Monday, which brought the total infections in the nation to 22,391 cases with 367 deaths to be exact. A horrendous reality of this invisible enemy that South Koreans and the world as a whole face daily.
In relevance to which, last July, SK Bioscience agreed in convention to manufacture the experimental vaccine of AstraZeneca’s which has shown great and purposeful promise, and has relatively signed a deal with Novavax Inc. during the previous month, in the production of a component that will respectively come from the U.S. based drug developer’s experimental coronavirus vaccine.
The South Korean government has maximally continued their health initiatives and efforts in order to strengthen the fight against COVID-19, even at the beginning of the pandemic outbreak in the nation up to this day. The thrust of minimizing and eventually abolishing the horrendous virus is an achievable target and goal as foreseen by the built partnership of the health authorities and government officials of South Korea.
Discipline and Obedience is highly implied to be gained from the citizens, individuals and nationalities living in South Korea as emphasized daily by the national government, in order to win the battle against COVID-19.
Tasks that are set in place both for the Health Sector and the Public Service Sector may be a toll at times, yet the utmost dedication and commitment of the frontliners, in the realms of South Korea is testament to the evidence that they will eventually be at the top of this battle beset by this invisible threat beyond the human individual’s naked eye.